Schilpario, Italy

Matteo Bonaldi

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Erregierre S.p.a.. Active years: 2013-2017.


 

Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Schilpario, IT (2013 - 2014)
  • Sorisole, IT (2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Matteo Bonaldi: Innovator in Pharmaceutical Processes

Introduction

Matteo Bonaldi is a notable inventor based in Schilpario, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important compounds. With a total of 3 patents to his name, Bonaldi continues to push the boundaries of innovation in his industry.

Latest Patents

One of Bonaldi's latest patents is titled "Process for the preparation of toltrazuril and an intermediate useful for its preparation." This invention discloses a method for synthesizing toltrazuril using a novel intermediate, which avoids the use of potentially hazardous reagents or unstable intermediates. Another significant patent is "Process for preparing vilazodone hydrochloride." This process involves a series of reactions that ultimately yield vilazodone in its free base form, which is then converted into its hydrochloride form.

Career Highlights

Matteo Bonaldi works at Erregierre S.p.a., a company known for its focus on pharmaceutical innovations. His work has been instrumental in developing safer and more efficient methods for drug preparation, contributing to advancements in the pharmaceutical industry.

Collaborations

Throughout his career, Bonaldi has collaborated with talented individuals such as Massimo Ferrari and Daniele De Zani. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Matteo Bonaldi is a prominent figure in the pharmaceutical field, recognized for his innovative processes and contributions to drug development. His work continues to impact the industry positively, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…